Eagle Wealth Strategies »

Akebia Therapeutics shares owned by Eagle Wealth Strategies

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Eagle Wealth Strategies from 13F filings

Historical chart of Eagle Wealth Strategies investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Eagle Wealth Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Eagle Wealth Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 12k 1.63
2023-12-31 $25k 20k 1.24

More positions owned by Eagle Wealth Strategies

Vanguard Index Fds S&p 500 Etf Shs (VOO)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Accenture Plc Ireland Shs Class A (ACN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Arthur J. Gallagher & Co. (AJG)
Apple (AAPL)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Fulton Financial (FULT)
Amazon (AMZN)

View all positions for Eagle Wealth Strategies

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Acadian Asset Management
Millennium Management
Susquehanna International
BlackRock
Qube Research & Technologies
Geode Capital Management
Jacobs Levy Equity Management
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Marshall Wace
Federated Investors
Assenagon Asset Management
Morgan Stanley

View all funds holding Akebia Therapeutics